Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
To evaluate among patients with untreated advanced ADC-CBA, impact on the disease control
rate after 4 months treatment of an early therapeutic permutation with the first month in the
absence of stabilization or objective answer.
Phase:
Phase 2
Details
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique